
Merck
Europe, Hessen, Germany, Darmstadt
Description
Merck is a pharmaceutical and chemical enterprise that develops prescription drugs and over-the-counter products.
Investor Profile
Merck has backed more than 14 startups, with 1 new investments in the last 12 months alone. The firm has led 8 rounds, about 57% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Grant, Series A, Seed rounds (top funding stages).
- Majority of deals are located in United States, Germany, China.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Led 1 rounds in the past year.
Stage Focus
- Grant (21%)
- Series A (14%)
- Seed (14%)
- Series Unknown (14%)
- Post Ipo Equity (14%)
- Series B (7%)
- Series C (7%)
- Series H (7%)
Country Focus
- United States (71%)
- Germany (7%)
- China (7%)
- United Kingdom (7%)
- The Netherlands (7%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Life Science
- Therapeutics
- Biopharma
- Oncology
- Artificial Intelligence (Ai)
- Big Data
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Merck frequently co-invest with?
What are some of recent deals done by Merck?
Find More Investors Like Merck
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









